The purpose of this study was to assess the willingness of intravenous drug users to participate in a preventive human immunodeficency virus (HIV) vaccine efficacy trial.
Of the 347 intravenous drug users in methadone treatment who were approached for participation, 257 completed a battery of self-administered questionnaires assessing risk behaviors, interest in vaccine trials, and other vaccine-related information.
Data from 16 known seropositives and 1 inconsistent responder were dropped from analyses (n=240).
Mots-clés Pascal : Toxicomanie, Voie intraveineuse, Motivation, Participation, Vaccination, Prévention, SIDA, Virose, Infection, Essai clinique, Homme, Volontaire, Pennsylvanie, Etats Unis, Amérique du Nord, Amérique, Immunopathologie, Immunodéficit
Mots-clés Pascal anglais : Drug addiction, Intravenous administration, Motivation, Participation, Vaccination, Prevention, AIDS, Viral disease, Infection, Clinical trial, Human, Volunteer, Pennsylvania, United States, North America, America, Immunopathology, Immune deficiency
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 94-0447294
Code Inist : 002B06D01. Création : 199406.